Stockreport

Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology [Yahoo! Finance]

ONO PHARM CO UNSP/ADR  (OPHLY) 
NASDAQ:AMEX Investor Relations: ono.co.jp/eng/investor/index.html
PDF Expanded collaboration into Ono's other priority areas of interest, including neurology and immunology, following the ongoing partnership in oncology Obtaining exclus [Read more]